Published in Medical Letter on the CDC and FDA, January 7th, 2007
Further, Cordis committed to support efforts by the clinical community, medical societies and industry to achieve these goals. The company's conclusions are based on an independent analysis of long-term clinical data for the CYPHER Stent that were presented recently.
This independent analysis, conducted and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.